Paul O’Donnell

<i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Maria Fernanda Amary, Krisztián Bácsi, Francesca Maggiani et al. · The Journal of Pathology · 2011 · 994 citations · Full text

Medicine, Genetics, Oncology +16

Brachyury Expression in Extra-axial Skeletal and Soft Tissue Chordomas: A Marker that Distinguishes Chordoma From Mixed Tumor/Myoepithelioma/Parachordoma in Soft Tissue

Roberto Tirabosco, D. Chas Mangham, Andrew E. Rosenberg et al. · The American Journal of Surgical Pathology · 2008 · 248 citations

Medicine, Oncology, Pathology +14

H3F3A (Histone 3.3) G34W Immunohistochemistry

Fernanda Amary, Fitim Berisha, Hongtao Ye et al. · The American Journal of Surgical Pathology · 2017 · 219 citations · Full text

Medicine, Oncology, Pathology +16

MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification

Mélanie Brisson, Takeshi Kashima, David Delaney et al. · Skeletal Radiology · 2012 · 144 citations

Veterinary Medicine, Oncology, Pathology +15

The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma

Maria Fernanda Amary, Fitim Berisha, Rafael Mozela et al. · Histopathology · 2016 · 135 citations

Medicine, Oncology, Pathology +11